A mental health condition triggered by traumatic events. Often characterized by persistent anxiety, flashbacks, and distressing memories.
This study aimed to evaluate the efficacy of psilocybin therapy in reducing symptoms of depression, burnout, and PTSD in frontline clinicians affected by the COVID-19 pandemic.
This study aims to explore the risks associated with psychedelic-assisted therapies (PATs) by evaluating potential adverse events (AEs) to develop a comprehensive and standardized assessment framework.
This study explored the therapeutic role of psilocybin in helping individuals recover from sexual abuse-related PTSD by focusing on the interplay of memory retrieval and narrative reconstruction in healing.
A study reveals potential benefits and risks of psychedelics for individuals with psychotic disorders, emphasizing personal growth and mystical experiences.
This study critically reviews randomized controlled trials (RCTs) of MDMA-assisted therapy (MDMA-AT) for PTSD, focusing on efficacy, methodological issues, and future research directions.